Most head and neck cancers are squamous cell carcinomas that develop in the upper
aerodigestive epithelium after exposure to carcinogens such as tobacco and alcohol …

The prototypic head and neck squamous cell carcinoma (HNSCC) arises from the mucosal
lining of the upper aerodigestive tract, demonstrates squamous differentiation …

Purpose Combining cisplatin or cetuximab with radiation improves overall survival (OS) of
patients with stage III or IV head and neck carcinoma (HNC). Cetuximab plus platinum …

Purpose We tested the efficacy and toxicity of cisplatin plus accelerated fractionation with a
concomitant boost (AFX-C) versus standard fractionation (SFX) in locally advanced head …

PURPOSE Pembrolizumab is a humanized monoclonal antibody that blocks interaction
between programmed death receptor-1 (PD-1) and its ligands (PD-L1, PD-L2). Although …

Since the inception of this journal in 1948, the understanding of etiologic factors that
contribute to and the treatment of head and neck cancer has evolved dramatically. Advances …

The relationship between chemotherapy and arrhythmias has not been well established. We
reviewed the existing literature to better understand this connection. We reviewed published …

In this article, we use the example of head and neck cancer to show how concurrent
chemoradiotherapy is used to treat a cancer where locoregional control is central for …

Cetuximab is a novel therapeutic monoclonal antibody with two N-glycosylation sites: a
conserved site in the CH2 domain and a second site within the framework 3 of the variable …

Purpose: To perform a retrospective analysis of patients with paranasal sinus (PNS) cancer
treated with postoperative radiotherapy (RT) at Memorial Sloan-Kettering Cancer Center …